These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8298143)

  • 41. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype.
    Federici AB; Mannucci PM; Stabile F; Canciani MT; Di Rocco N; Miyata S; Ware J; Ruggeri ZM
    Thromb Haemost; 1997 Sep; 78(3):1132-7. PubMed ID: 9308766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
    Matsushita T; Sadler JE
    J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728.
    Fujimura Y; Holland LZ; Ruggeri ZM; Zimmerman TS
    Blood; 1987 Oct; 70(4):985-8. PubMed ID: 3498523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications.
    Hilbert L; Federici AB; Baronciani L; Dallagiovanna S; Mazurier C
    Haematologica; 2004 Sep; 89(9):1128-33. PubMed ID: 15377475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers.
    O'Brien LA; Sutherland JJ; Hegadorn C; Benford K; Racz H; Rapson D; Hough C; Lillicrap D
    J Thromb Haemost; 2004 Jul; 2(7):1135-42. PubMed ID: 15219197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease.
    Hommais A; Stépanian A; Fressinaud E; Mazurier C; Pouymayou K; Meyer D; Girma JP; Ribba AS
    Thromb Haemost; 2006 May; 95(5):776-81. PubMed ID: 16676067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C; Hilbert L; Mazurier C
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A variant of type II von Willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von Willebrand factor structure.
    Gralnick HR; Williams SB; McKeown LP; Maisonneuve P; Jenneau C; Sultan Y
    Am J Hematol; 1987 Mar; 24(3):259-66. PubMed ID: 3493688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of Leu777Pro and Ile865Thr type IIA von Willebrand disease mutations.
    Lyons SE; Cooney KA; Bockenstedt P; Ginsburg D
    Blood; 1994 Mar; 83(6):1551-7. PubMed ID: 8123844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.
    Murata M; Russell SR; Ruggeri ZM; Ware J
    J Clin Invest; 1993 May; 91(5):2133-7. PubMed ID: 8486780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).
    Zimmerman TS; Dent JA; Ruggeri ZM; Nannini LH
    J Clin Invest; 1986 Mar; 77(3):947-51. PubMed ID: 3485111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease.
    Schneppenheim R; Budde U; Obser T; Brassard J; Mainusch K; Ruggeri ZM; Schneppenheim S; Schwaab R; Oldenburg J
    Blood; 2001 Apr; 97(7):2059-66. PubMed ID: 11264172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami.
    Ledford MR; Rabinowitz I; Sadler JE; Kent JW; Civantos F
    Blood; 1993 Jul; 82(1):169-75. PubMed ID: 8324222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor.
    Jorieux S; Tuley EA; Gaucher C; Mazurier C; Sadler JE
    Blood; 1992 Feb; 79(3):563-7. PubMed ID: 1732004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease.
    Casonato A; Sartori MT; Bertomoro A; Fede T; Vasoin F; Girolami A
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):33-40. PubMed ID: 1772996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular basis of von Willebrand disease.
    Mazurier C; Meyer D
    Baillieres Clin Haematol; 1996 Jun; 9(2):229-41. PubMed ID: 8800502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.